Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 745,457 $ 592,053
Accounts receivable, net 0 500
Grant receivable 103,000 224,879
Prepaid expenses 123,171 157,493
Total current assets 971,628 974,925
Property and equipment, net 109,411 128,605
Right to use assets 412,030 489,536
Other assets:    
Patents, net 11,680 12,564
Software development costs 35,985 0
Intellectual property, net 0 176,850
Deposits, long term 44,520 44,520
Total other assets 92,185 233,934
Total assets 1,585,254 1,827,000
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $925,878 and $686,068, respectively 2,880,569 2,490,158
Deferred revenue, short term 34,981 63,331
Deferred revenue-grant 0 65,560
Lease liability, short term 116,276 106,290
Notes payable 221,480 21,480
Notes payable, related parties 790,110 290,110
PPP loan, short term 25,100 15,445
Total current liabilities 4,068,516 3,052,374
Long term liabilities:    
PPP loan, long term 106,340 12,555
EIDL loan, long term 74,300 74,300
Royalty obligation, net of discount of $5,976,000 and $6,331,662, related parties 2,746,100 2,390,438
Lease liability, long term 347,098 435,405
Deferred revenue, long term 46,118 72,281
Total liabilities 7,388,472 6,037,353
Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, 6,642,279 and 5,463,444 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 6,642 5,463
Common stock subscribed 100,000 100,000
Additional paid in capital 62,881,494 60,466,333
Accumulated deficit (68,695,650) (64,688,311)
Total deficit attributable to BioCorRx, Inc. (5,685,898) (4,094,899)
Non-controlling interest (117,320) (115,454)
Total deficit (5,803,218) (4,210,353)
Total liabilities and deficit 1,585,254 1,827,000
Series A Preferred Shares [Member]    
Deficit:    
Preferred stock value 16,000 16,000
Series B Preferred Shares [Member]    
Deficit:    
Preferred stock value $ 5,616 $ 5,616